Tasly Pharmaceutical Group Co., Ltd (600535.SS) SHH

15.22

-0.1(-0.65%)

Updated at December 05 10:24AM

Currency In CNY

Valuation

Market Cap21.59B
Enterprise Value19.62B
P/E Ratio20.85
PEG Ratio7.51
Price/Sales Ratio2.74
Price/Book Ratio1.86
Enterprise/Revenue2.54
Enterprise/EBITDA13.53

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.13
Operating Margin0.15

Management Effectiveness

Return On Assets0.07
Return On Equity0.09

Income Statement

Revenue8.5B
Revenue/Share5.59
Gross Profit5.69B
EBITDA1.83B
Net Income955.59M
Diluted EPS0.64

Balance Sheet

Total Cash3.49B
Total Cash/Share2.34
Total Debt920.05M
Total Debt/Equity0.07
Current Ratio3.82
Book Value Per Share8.37

Price History

52-Week Change5.51
52-Week High17.69
52-Week Low13.51
Moving Average 50 Days15.6
Moving Average 200 Days15.74

Statistics

Average Volume13.99M
Shares Outstanding1.49B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.41
Trailing Annual Dividend Yield2.68
Payout Ratio0.75
Last Split Factor7:5
Last Split DateJune 05, 2018